Amyloidosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 9: | Line 9: | ||
==[[Amyloidosis historical perspective|Historical Perspective]]== | ==[[Amyloidosis historical perspective|Historical Perspective]]== | ||
== Classification == | == Classification == | ||
Line 70: | Line 68: | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
<references /> |
Revision as of 14:53, 12 June 2018
Amyloidosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Amyloidosis On the Web |
American Roentgen Ray Society Images of Amyloidosis |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
Historical Perspective
Classification
Amyloidosis may be classified based on precursor of amyloidogenic protein into different subtypes, include:[1][2]
Type | Amyloidogenic protein/ fibril | Clinical syndrome |
---|---|---|
AL | Light chains of immunoglobulines (most common type) | Monoclonal gammopathy |
AA | Serum amyloid A protein | Chronic inflammatory diseases |
AF | Mutant transthyretin, A1-apolipoprotein, gelsolin, fibrinogen, etc. | Familial polyneuropathy/cardiomyopathy/nephropathy |
ATTRwt | Wild-type transthyretin | Senile restrictive cardiomyopathy _ Transthyretin-related amyloidosis wild-type |
AH | ß2-microglobulin | Long-term hemodialysis |
Pathophysiology
Causes
Differentiating Amyloidosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
- ↑ Real de Asúa D, Costa R, Galván JM, Filigheddu MT, Trujillo D, Cadiñanos J (2014). "Systemic AA amyloidosis: epidemiology, diagnosis, and management". Clin Epidemiol. 6: 369–77. doi:10.2147/CLEP.S39981. PMC 4218891. PMID 25378951.
- ↑ Misumi Y, Ando Y (July 2014). "[Classification of amyloidosis]". Brain Nerve (in Japanese). 66 (7): 731–7. PMID 24998818.